We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

311 hedge funds and large institutions have $3.72B invested in Editas Medicine in 2020 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 87 increasing their positions, 69 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

235% more first-time investments, than exits

New positions opened: 104 | Existing positions closed: 31

140% more capital invested

Capital invested by funds: $1.55B → $3.72B (+$2.17B)

40% more call options, than puts

Call options by funds: $188M | Put options by funds: $134M

30% more funds holding

Funds holding: 239 → 311 (+72)

26% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 69

3.56% less ownership

Funds ownership: 88.57% → 85.02% (-3.6%)

Holders
311
Holders Change
+72
Holders Change %
+30.13%
% of All Funds
5.5%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
104
Increased
87
Reduced
69
Closed
31
Calls
$188M
Puts
$134M
Net Calls
+$53.9M
Net Calls Change
+$35M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$16.8M
2
Voloridge Investment Management
Voloridge Investment Management
Florida
+$16.7M
3
GLA
Great Lakes Advisors
Illinois
+$15.6M
4
SOMRS
State of Michigan Retirement System
Michigan
+$12.6M
5
JP Morgan Chase
JP Morgan Chase
New York
+$5.13M

Top Sellers

Rank Fund Capital Flow
1
NAMA
Nikko Asset Management Americas
New York
-$28.2M
2
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$28.2M
3
State Street
State Street
Massachusetts
-$26.4M
4
AIM
ARK Investment Management
Florida
-$22.4M
5
DM
Deerfield Management
New York
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
CFN
251
Cordasco Financial Network
Florida
$29K +$493 +12 +3%
SFS
252
Sowell Financial Services
Arkansas
$28K -$11.4K -278 -41%
CG
253
Cutler Group
California
$28K – – –
HNB
254
Huntington National Bank
Ohio
$28K +$1.23K +30 +8%
RAM
255
Riggs Asset Management
Pennsylvania
$28K +$16.4K +400 New
ICM
256
Islay Capital Management
Texas
$25K -$6.16K -150 -30%
RG
257
Retirement Group
California
$22K – – –
WIM
258
Westside Investment Management
California
$21.3K +$10.3K +250 +7%
CTC
259
Central Trust Company
Missouri
$21K – – –
WT
260
Whittier Trust
California
$21K – – –
BDWM
261
Brewin Dolphin Wealth Management
Ireland
$19.6K – – –
HIA
262
Harbor Investment Advisory
Maryland
$19K +$822 +20 +8%
JPLA
263
Joseph P. Lucia & Associates
New York
$17K +$9.78K +238 New
RE
264
RBC Europe
United Kingdom
$15.2K +$2.05K +50 +30%
First Manhattan
265
First Manhattan
New York
$14K – – –
MF
266
Manchester Financial
California
$14K – – –
SBL
267
Sargent Bickham Lagudis
Colorado
$14K – – –
TFA
268
Toth Financial Advisory
Virginia
$14K – – –
NFG
269
Next Financial Group
Texas
$14K +$3.7K +90 +87%
PA
270
Parallel Advisors
California
$14K +$4.6K +112 +119%
S
271
SignatureFD
Georgia
$13K +$1.64K +40 +27%
QT
272
Quantbot Technologies
New York
$12K +$7.39K +180 New
KFI
273
Key Financial Inc
Pennsylvania
$11K +$6.16K +150 New
SIS
274
Sound Income Strategies
Florida
$11K +$6.41K +156 New
IAIM
275
International Assets Investment Management
Florida
$11K +$6.57K +160 New
9 10
11
12 13

EDIT Hedge Fund Activity: Q4 2020 in Review

311 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q4 2020, worth a combined $3.72B — up 140% from $1.55B a quarter earlier.

Buyers outnumbered sellers: 104 funds opened new EDIT positions and 31 closed out — a net gain of 73 holders — while 87 added to existing stakes and 69 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $16.8M. The largest seller was Nikko Asset Management Americas, cutting an estimated $28.2M.

  • 311 institutional investors held Editas Medicine (EDIT) as of Q4 2020, up from 239 in Q3 2020.
  • Funds reported $3.72B of Editas Medicine stock for Q4 2020, up 140% quarter-over-quarter.
  • 104 funds opened new Editas Medicine positions in Q4 2020 and 31 closed out, a net change of +73 holders.
  • The largest Editas Medicine buyer in Q4 2020 was D.E. Shaw & Co, an estimated $16.8M added.
  • The largest Editas Medicine seller in Q4 2020 was Nikko Asset Management Americas, an estimated $28.2M sold.

Based on aggregated 13F filings for Q4 2020.